Proto Labs, Inc. |
|||||||||
Reconciliation of GAAP to Non-GAAP Operating Margin |
|||||||||
(In thousands) |
|||||||||
(Unaudited) |
|||||||||
|
|
|
|
|
|||||
|
|
|
Three Months Ended |
||||||
|
|
|
March 31, |
||||||
|
|
|
2020 |
|
|
2019 |
|||
Revenue | $ |
115,108 |
|
$ |
113,452 |
|
|||
Income from operations |
|
16,825 |
|
|
19,448 |
|
|||
GAAP operating margin |
|
14.6 |
% |
|
17.1 |
% |
|||
Add back: | |||||||||
Stock-based compensation expense |
|
3,033 |
|
|
3,040 |
|
|||
Amortization expense |
|
754 |
|
|
871 |
|
|||
Total adjustments |
|
3,787 |
|
|
3,911 |
|
|||
Non-GAAP income from operations | $ |
20,612 |
|
$ |
23,359 |
|
|||
Non-GAAP operating margin |
|
17.9 |
% |
|
20.6 |
% |
|||